nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenytoin—CYP2C18—prostate cancer	0.134	0.418	CbGaD
Phenytoin—CYP3A5—prostate cancer	0.0881	0.275	CbGaD
Phenytoin—CYP2C19—prostate cancer	0.0599	0.187	CbGaD
Phenytoin—CYP3A4—prostate cancer	0.0381	0.119	CbGaD
Phenytoin—SLCO1C1—Conjugated Estrogens—prostate cancer	0.037	0.0863	CbGbCtD
Phenytoin—SLCO1C1—Estradiol—prostate cancer	0.0324	0.0757	CbGbCtD
Phenytoin—ABCC2—Ethinyl Estradiol—prostate cancer	0.0144	0.0336	CbGbCtD
Phenytoin—ALB—Abiraterone—prostate cancer	0.0139	0.0325	CbGbCtD
Phenytoin—CYP2C8—Nilutamide—prostate cancer	0.013	0.0303	CbGbCtD
Phenytoin—CYP3A5—Flutamide—prostate cancer	0.0112	0.0261	CbGbCtD
Phenytoin—CYP2C19—Bicalutamide—prostate cancer	0.0109	0.0254	CbGbCtD
Phenytoin—CYP2C19—Nilutamide—prostate cancer	0.0109	0.0254	CbGbCtD
Phenytoin—CYP2C8—Abiraterone—prostate cancer	0.0108	0.0251	CbGbCtD
Phenytoin—ABCC2—Conjugated Estrogens—prostate cancer	0.0106	0.0247	CbGbCtD
Phenytoin—CYP2B6—Estrone—prostate cancer	0.0103	0.024	CbGbCtD
Phenytoin—ALB—Estrone—prostate cancer	0.0101	0.0235	CbGbCtD
Phenytoin—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.01	0.0234	CbGbCtD
Phenytoin—CYP2B6—Ethinyl Estradiol—prostate cancer	0.00915	0.0214	CbGbCtD
Phenytoin—CYP2C9—Nilutamide—prostate cancer	0.00905	0.0211	CbGbCtD
Phenytoin—CYP2C9—Bicalutamide—prostate cancer	0.00905	0.0211	CbGbCtD
Phenytoin—CYP2C19—Flutamide—prostate cancer	0.00902	0.0211	CbGbCtD
Phenytoin—CYP3A5—Cabazitaxel—prostate cancer	0.00827	0.0193	CbGbCtD
Phenytoin—ABCB1—Estramustine—prostate cancer	0.00817	0.0191	CbGbCtD
Phenytoin—CYP3A5—Estrone—prostate cancer	0.00809	0.0189	CbGbCtD
Phenytoin—CYP2C8—Cabazitaxel—prostate cancer	0.00796	0.0186	CbGbCtD
Phenytoin—CYP2C8—Ethinyl Estradiol—prostate cancer	0.00693	0.0162	CbGbCtD
Phenytoin—CYP3A7—Estradiol—prostate cancer	0.00619	0.0145	CbGbCtD
Phenytoin—CYP3A7-CYP3A51P—Estradiol—prostate cancer	0.00619	0.0145	CbGbCtD
Phenytoin—ABCC2—Etoposide—prostate cancer	0.00605	0.0141	CbGbCtD
Phenytoin—ALB—Estradiol—prostate cancer	0.00578	0.0135	CbGbCtD
Phenytoin—ABCC2—Docetaxel—prostate cancer	0.00554	0.0129	CbGbCtD
Phenytoin—CYP2C9—Estrone—prostate cancer	0.00542	0.0127	CbGbCtD
Phenytoin—ABCB1—Cabazitaxel—prostate cancer	0.00539	0.0126	CbGbCtD
Phenytoin—CYP3A4—Bicalutamide—prostate cancer	0.00526	0.0123	CbGbCtD
Phenytoin—ABCB1—Estrone—prostate cancer	0.00526	0.0123	CbGbCtD
Phenytoin—ALB—Prednisone—prostate cancer	0.00497	0.0116	CbGbCtD
Phenytoin—CYP3A4—Estramustine—prostate cancer	0.00489	0.0114	CbGbCtD
Phenytoin—ABCB1—Ethinyl Estradiol—prostate cancer	0.00469	0.0109	CbGbCtD
Phenytoin—CYP3A5—Estradiol—prostate cancer	0.00464	0.0108	CbGbCtD
Phenytoin—CYP2C8—Estradiol—prostate cancer	0.00447	0.0104	CbGbCtD
Phenytoin—CYP3A4—Abiraterone—prostate cancer	0.00436	0.0102	CbGbCtD
Phenytoin—CYP3A4—Flutamide—prostate cancer	0.00436	0.0102	CbGbCtD
Phenytoin—ABCC2—Doxorubicin—prostate cancer	0.00413	0.00964	CbGbCtD
Phenytoin—CYP2C9—Capecitabine—prostate cancer	0.00411	0.00959	CbGbCtD
Phenytoin—CYP2C19—Estradiol—prostate cancer	0.00375	0.00874	CbGbCtD
Phenytoin—CYP3A7-CYP3A51P—Docetaxel—prostate cancer	0.0037	0.00863	CbGbCtD
Phenytoin—CYP3A7—Docetaxel—prostate cancer	0.0037	0.00863	CbGbCtD
Phenytoin—ABCB1—Conjugated Estrogens—prostate cancer	0.00344	0.00804	CbGbCtD
Phenytoin—CYP3A4—Cabazitaxel—prostate cancer	0.00323	0.00753	CbGbCtD
Phenytoin—CYP2C19—Prednisone—prostate cancer	0.00322	0.00752	CbGbCtD
Phenytoin—CYP3A4—Estrone—prostate cancer	0.00315	0.00736	CbGbCtD
Phenytoin—ABCB1—Mitoxantrone—prostate cancer	0.00313	0.00731	CbGbCtD
Phenytoin—CYP2C9—Estradiol—prostate cancer	0.00311	0.00727	CbGbCtD
Phenytoin—CYP3A5—Etoposide—prostate cancer	0.00303	0.00708	CbGbCtD
Phenytoin—ABCB1—Estradiol—prostate cancer	0.00302	0.00706	CbGbCtD
Phenytoin—CYP2C8—Etoposide—prostate cancer	0.00292	0.00681	CbGbCtD
Phenytoin—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00281	0.00656	CbGbCtD
Phenytoin—CYP3A5—Docetaxel—prostate cancer	0.00277	0.00648	CbGbCtD
Phenytoin—CYP2B6—Doxorubicin—prostate cancer	0.00263	0.00613	CbGbCtD
Phenytoin—ABCB1—Prednisone—prostate cancer	0.0026	0.00607	CbGbCtD
Phenytoin—CYP3A4—Conjugated Estrogens—prostate cancer	0.00206	0.00481	CbGbCtD
Phenytoin—ABCB1—Etoposide—prostate cancer	0.00197	0.00461	CbGbCtD
Phenytoin—CYP3A4—Mitoxantrone—prostate cancer	0.00188	0.00438	CbGbCtD
Phenytoin—CYP3A4—Estradiol—prostate cancer	0.00181	0.00423	CbGbCtD
Phenytoin—ABCB1—Docetaxel—prostate cancer	0.00181	0.00421	CbGbCtD
Phenytoin—CYP3A4—Prednisone—prostate cancer	0.00156	0.00364	CbGbCtD
Phenytoin—ABCB1—Doxorubicin—prostate cancer	0.00135	0.00314	CbGbCtD
Phenytoin—CYP2C19—urine—prostate cancer	0.00126	0.0839	CbGeAlD
Phenytoin—CYP3A4—Etoposide—prostate cancer	0.00118	0.00276	CbGbCtD
Phenytoin—CYP3A4—Docetaxel—prostate cancer	0.00108	0.00253	CbGbCtD
Phenytoin—SCN9A—prostate gland—prostate cancer	0.00102	0.0675	CbGeAlD
Phenytoin—CYP2C9—urine—prostate cancer	0.000979	0.0651	CbGeAlD
Phenytoin—SCN4A—prostate gland—prostate cancer	0.000906	0.0603	CbGeAlD
Phenytoin—CYP3A4—Doxorubicin—prostate cancer	0.000807	0.00188	CbGbCtD
Phenytoin—CYP3A4—urine—prostate cancer	0.000746	0.0496	CbGeAlD
Phenytoin—SCN3A—prostate gland—prostate cancer	0.000705	0.0469	CbGeAlD
Phenytoin—SLCO1C1—renal system—prostate cancer	0.000672	0.0447	CbGeAlD
Phenytoin—SCN4A—renal system—prostate cancer	0.000618	0.0411	CbGeAlD
Phenytoin—ABCC2—prostate gland—prostate cancer	0.000527	0.0351	CbGeAlD
Phenytoin—SCN8A—testis—prostate cancer	0.000509	0.0339	CbGeAlD
Phenytoin—SCN3A—renal system—prostate cancer	0.000481	0.0319	CbGeAlD
Phenytoin—SCN9A—testis—prostate cancer	0.000448	0.0298	CbGeAlD
Phenytoin—SLCO1C1—testis—prostate cancer	0.000434	0.0289	CbGeAlD
Phenytoin—SCN4A—testis—prostate cancer	0.000399	0.0265	CbGeAlD
Phenytoin—SCN3A—bone marrow—prostate cancer	0.000363	0.0242	CbGeAlD
Phenytoin—ABCC2—renal system—prostate cancer	0.000359	0.0239	CbGeAlD
Phenytoin—CYP3A5—prostate gland—prostate cancer	0.000357	0.0237	CbGeAlD
Phenytoin—SCN9A—lymph node—prostate cancer	0.000324	0.0216	CbGeAlD
Phenytoin—SLCO1C1—lymph node—prostate cancer	0.000315	0.0209	CbGeAlD
Phenytoin—Carbamazepine—RALBP1—prostate cancer	0.000311	0.117	CrCbGaD
Phenytoin—SCN3A—testis—prostate cancer	0.000311	0.0206	CbGeAlD
Phenytoin—CYP2C8—renal system—prostate cancer	0.00027	0.0179	CbGeAlD
Phenytoin—ALB—testis—prostate cancer	0.000248	0.0165	CbGeAlD
Phenytoin—CYP3A5—renal system—prostate cancer	0.000243	0.0162	CbGeAlD
Phenytoin—CYP2B6—renal system—prostate cancer	0.000242	0.0161	CbGeAlD
Phenytoin—ABCC2—testis—prostate cancer	0.000232	0.0154	CbGeAlD
Phenytoin—SCN3A—lymph node—prostate cancer	0.000225	0.015	CbGeAlD
Phenytoin—ABCB1—prostate gland—prostate cancer	0.00019	0.0126	CbGeAlD
Phenytoin—CYP3A4—renal system—prostate cancer	0.000183	0.0121	CbGeAlD
Phenytoin—ALB—lymph node—prostate cancer	0.00018	0.0119	CbGeAlD
Phenytoin—CYP2C8—testis—prostate cancer	0.000174	0.0116	CbGeAlD
Phenytoin—Warfarin—CYP2C18—prostate cancer	0.00017	0.0642	CrCbGaD
Phenytoin—ABCC2—lymph node—prostate cancer	0.000168	0.0112	CbGeAlD
Phenytoin—ABCB1—seminal vesicle—prostate cancer	0.00016	0.0107	CbGeAlD
Phenytoin—CYP2B6—testis—prostate cancer	0.000156	0.0104	CbGeAlD
Phenytoin—ABCB1—epithelium—prostate cancer	0.000139	0.00926	CbGeAlD
Phenytoin—ABCB1—renal system—prostate cancer	0.000129	0.00859	CbGeAlD
Phenytoin—ABCB1—urethra—prostate cancer	0.000127	0.00844	CbGeAlD
Phenytoin—Methsuximide—CYP2C19—prostate cancer	0.000127	0.0478	CrCbGaD
Phenytoin—Fosphenytoin—CYP2C19—prostate cancer	0.000126	0.0474	CrCbGaD
Phenytoin—Phenobarbital—CYP2C18—prostate cancer	0.000119	0.0447	CrCbGaD
Phenytoin—Phenobarbital—CYP1B1—prostate cancer	9.81e-05	0.037	CrCbGaD
Phenytoin—ABCB1—bone marrow—prostate cancer	9.77e-05	0.0065	CbGeAlD
Phenytoin—Diphenhydramine—CYP2C18—prostate cancer	9.69e-05	0.0366	CrCbGaD
Phenytoin—Modafinil—CYP3A5—prostate cancer	9.19e-05	0.0347	CrCbGaD
Phenytoin—Primidone—CYP2C19—prostate cancer	8.42e-05	0.0318	CrCbGaD
Phenytoin—Carbamazepine—CYP3A5—prostate cancer	8.38e-05	0.0316	CrCbGaD
Phenytoin—ABCB1—testis—prostate cancer	8.35e-05	0.00555	CbGeAlD
Phenytoin—Fosphenytoin—CYP3A4—prostate cancer	7.98e-05	0.0301	CrCbGaD
Phenytoin—Diphenhydramine—SLC22A1—prostate cancer	7.91e-05	0.0298	CrCbGaD
Phenytoin—Methylphenobarbital—CYP2C19—prostate cancer	7.9e-05	0.0298	CrCbGaD
Phenytoin—Phenobarbital—CYP3A5—prostate cancer	7.81e-05	0.0295	CrCbGaD
Phenytoin—Warfarin—CYP2C19—prostate cancer	7.63e-05	0.0288	CrCbGaD
Phenytoin—Warfarin—CYP1A1—prostate cancer	7.6e-05	0.0287	CrCbGaD
Phenytoin—Phenobarbital—CYP2A6—prostate cancer	7.56e-05	0.0285	CrCbGaD
Phenytoin—Oxaprozin—PTGS2—prostate cancer	7.52e-05	0.0284	CrCbGaD
Phenytoin—Modafinil—CYP2C19—prostate cancer	6.25e-05	0.0236	CrCbGaD
Phenytoin—ABCB1—lymph node—prostate cancer	6.05e-05	0.00403	CbGeAlD
Phenytoin—Carbamazepine—CYP2C19—prostate cancer	5.71e-05	0.0215	CrCbGaD
Phenytoin—Phenprocoumon—CYP3A4—prostate cancer	5.47e-05	0.0206	CrCbGaD
Phenytoin—Phenobarbital—CYP2E1—prostate cancer	5.37e-05	0.0203	CrCbGaD
Phenytoin—Primidone—CYP3A4—prostate cancer	5.35e-05	0.0202	CrCbGaD
Phenytoin—Phenobarbital—CYP2C19—prostate cancer	5.32e-05	0.0201	CrCbGaD
Phenytoin—Phenobarbital—CYP1A1—prostate cancer	5.3e-05	0.02	CrCbGaD
Phenytoin—Phenylbutazone—CYP3A4—prostate cancer	5.08e-05	0.0192	CrCbGaD
Phenytoin—Phenylbutazone—PTGS2—prostate cancer	4.97e-05	0.0188	CrCbGaD
Phenytoin—Warfarin—CYP3A4—prostate cancer	4.85e-05	0.0183	CrCbGaD
Phenytoin—Diphenhydramine—CYP2C19—prostate cancer	4.34e-05	0.0164	CrCbGaD
Phenytoin—Modafinil—CYP3A4—prostate cancer	3.98e-05	0.015	CrCbGaD
Phenytoin—Carbamazepine—CYP3A4—prostate cancer	3.63e-05	0.0137	CrCbGaD
Phenytoin—Benzphetamine—CYP3A4—prostate cancer	3.45e-05	0.013	CrCbGaD
Phenytoin—Phenobarbital—CYP3A4—prostate cancer	3.38e-05	0.0128	CrCbGaD
Phenytoin—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	2.49e-05	0.00018	CcSEcCtD
Phenytoin—Bradycardia—Epirubicin—prostate cancer	2.48e-05	0.000179	CcSEcCtD
Phenytoin—Renal failure—Doxorubicin—prostate cancer	2.47e-05	0.000178	CcSEcCtD
Phenytoin—Infection—Capecitabine—prostate cancer	2.47e-05	0.000178	CcSEcCtD
Phenytoin—Urticaria—Etoposide—prostate cancer	2.46e-05	0.000177	CcSEcCtD
Phenytoin—Haemoglobin—Epirubicin—prostate cancer	2.45e-05	0.000177	CcSEcCtD
Phenytoin—Anorexia—Docetaxel—prostate cancer	2.45e-05	0.000177	CcSEcCtD
Phenytoin—Malaise—Prednisone—prostate cancer	2.45e-05	0.000177	CcSEcCtD
Phenytoin—Shock—Capecitabine—prostate cancer	2.45e-05	0.000177	CcSEcCtD
Phenytoin—Rhinitis—Epirubicin—prostate cancer	2.44e-05	0.000177	CcSEcCtD
Phenytoin—Body temperature increased—Etoposide—prostate cancer	2.44e-05	0.000176	CcSEcCtD
Phenytoin—Conjunctivitis—Doxorubicin—prostate cancer	2.44e-05	0.000176	CcSEcCtD
Phenytoin—Nervous system disorder—Capecitabine—prostate cancer	2.44e-05	0.000176	CcSEcCtD
Phenytoin—Vertigo—Prednisone—prostate cancer	2.44e-05	0.000176	CcSEcCtD
Phenytoin—Haemorrhage—Epirubicin—prostate cancer	2.44e-05	0.000176	CcSEcCtD
Phenytoin—Thrombocytopenia—Capecitabine—prostate cancer	2.43e-05	0.000176	CcSEcCtD
Phenytoin—Syncope—Prednisone—prostate cancer	2.43e-05	0.000176	CcSEcCtD
Phenytoin—Tachycardia—Capecitabine—prostate cancer	2.43e-05	0.000175	CcSEcCtD
Phenytoin—Hypoaesthesia—Epirubicin—prostate cancer	2.43e-05	0.000175	CcSEcCtD
Phenytoin—Pharyngitis—Epirubicin—prostate cancer	2.42e-05	0.000175	CcSEcCtD
Phenytoin—Sweating—Doxorubicin—prostate cancer	2.41e-05	0.000174	CcSEcCtD
Phenytoin—Hyperhidrosis—Capecitabine—prostate cancer	2.4e-05	0.000174	CcSEcCtD
Phenytoin—Hypotension—Docetaxel—prostate cancer	2.4e-05	0.000173	CcSEcCtD
Phenytoin—Connective tissue disorder—Epirubicin—prostate cancer	2.4e-05	0.000173	CcSEcCtD
Phenytoin—Loss of consciousness—Prednisone—prostate cancer	2.39e-05	0.000172	CcSEcCtD
Phenytoin—Hepatobiliary disease—Doxorubicin—prostate cancer	2.38e-05	0.000172	CcSEcCtD
Phenytoin—Epistaxis—Doxorubicin—prostate cancer	2.37e-05	0.000171	CcSEcCtD
Phenytoin—Anorexia—Capecitabine—prostate cancer	2.37e-05	0.000171	CcSEcCtD
Phenytoin—Nausea—Estradiol—prostate cancer	2.37e-05	0.000171	CcSEcCtD
Phenytoin—Vomiting—Mitoxantrone—prostate cancer	2.36e-05	0.000171	CcSEcCtD
Phenytoin—Sinusitis—Doxorubicin—prostate cancer	2.36e-05	0.00017	CcSEcCtD
Phenytoin—Convulsion—Prednisone—prostate cancer	2.35e-05	0.00017	CcSEcCtD
Phenytoin—Agranulocytosis—Doxorubicin—prostate cancer	2.35e-05	0.000169	CcSEcCtD
Phenytoin—Hypertension—Prednisone—prostate cancer	2.34e-05	0.000169	CcSEcCtD
Phenytoin—Rash—Mitoxantrone—prostate cancer	2.34e-05	0.000169	CcSEcCtD
Phenytoin—Dermatitis—Mitoxantrone—prostate cancer	2.34e-05	0.000169	CcSEcCtD
Phenytoin—Musculoskeletal discomfort—Docetaxel—prostate cancer	2.34e-05	0.000169	CcSEcCtD
Phenytoin—Headache—Mitoxantrone—prostate cancer	2.33e-05	0.000168	CcSEcCtD
Phenytoin—Hypotension—Capecitabine—prostate cancer	2.32e-05	0.000168	CcSEcCtD
Phenytoin—Insomnia—Docetaxel—prostate cancer	2.32e-05	0.000168	CcSEcCtD
Phenytoin—Arthralgia—Prednisone—prostate cancer	2.31e-05	0.000167	CcSEcCtD
Phenytoin—Myalgia—Prednisone—prostate cancer	2.31e-05	0.000167	CcSEcCtD
Phenytoin—Paraesthesia—Docetaxel—prostate cancer	2.31e-05	0.000167	CcSEcCtD
Phenytoin—Erythema multiforme—Epirubicin—prostate cancer	2.31e-05	0.000166	CcSEcCtD
Phenytoin—Bradycardia—Doxorubicin—prostate cancer	2.3e-05	0.000166	CcSEcCtD
Phenytoin—Dyspnoea—Docetaxel—prostate cancer	2.29e-05	0.000165	CcSEcCtD
Phenytoin—Somnolence—Docetaxel—prostate cancer	2.28e-05	0.000165	CcSEcCtD
Phenytoin—Discomfort—Prednisone—prostate cancer	2.28e-05	0.000165	CcSEcCtD
Phenytoin—Hypersensitivity—Etoposide—prostate cancer	2.28e-05	0.000164	CcSEcCtD
Phenytoin—Tinnitus—Epirubicin—prostate cancer	2.27e-05	0.000164	CcSEcCtD
Phenytoin—Haemoglobin—Doxorubicin—prostate cancer	2.27e-05	0.000164	CcSEcCtD
Phenytoin—Musculoskeletal discomfort—Capecitabine—prostate cancer	2.27e-05	0.000164	CcSEcCtD
Phenytoin—Rhinitis—Doxorubicin—prostate cancer	2.26e-05	0.000163	CcSEcCtD
Phenytoin—Dyspepsia—Docetaxel—prostate cancer	2.26e-05	0.000163	CcSEcCtD
Phenytoin—Haemorrhage—Doxorubicin—prostate cancer	2.26e-05	0.000163	CcSEcCtD
Phenytoin—Insomnia—Capecitabine—prostate cancer	2.25e-05	0.000162	CcSEcCtD
Phenytoin—Hypoaesthesia—Doxorubicin—prostate cancer	2.25e-05	0.000162	CcSEcCtD
Phenytoin—Pharyngitis—Doxorubicin—prostate cancer	2.24e-05	0.000162	CcSEcCtD
Phenytoin—Paraesthesia—Capecitabine—prostate cancer	2.23e-05	0.000161	CcSEcCtD
Phenytoin—Decreased appetite—Docetaxel—prostate cancer	2.23e-05	0.000161	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Docetaxel—prostate cancer	2.22e-05	0.00016	CcSEcCtD
Phenytoin—Asthenia—Etoposide—prostate cancer	2.22e-05	0.00016	CcSEcCtD
Phenytoin—Connective tissue disorder—Doxorubicin—prostate cancer	2.22e-05	0.00016	CcSEcCtD
Phenytoin—Dyspnoea—Capecitabine—prostate cancer	2.22e-05	0.00016	CcSEcCtD
Phenytoin—Anaphylactic shock—Prednisone—prostate cancer	2.22e-05	0.00016	CcSEcCtD
Phenytoin—Fatigue—Docetaxel—prostate cancer	2.21e-05	0.00016	CcSEcCtD
Phenytoin—Nausea—Mitoxantrone—prostate cancer	2.21e-05	0.000159	CcSEcCtD
Phenytoin—Immune system disorder—Epirubicin—prostate cancer	2.2e-05	0.000159	CcSEcCtD
Phenytoin—Infection—Prednisone—prostate cancer	2.2e-05	0.000159	CcSEcCtD
Phenytoin—Constipation—Docetaxel—prostate cancer	2.2e-05	0.000159	CcSEcCtD
Phenytoin—Dyspepsia—Capecitabine—prostate cancer	2.19e-05	0.000158	CcSEcCtD
Phenytoin—Chills—Epirubicin—prostate cancer	2.19e-05	0.000158	CcSEcCtD
Phenytoin—Pruritus—Etoposide—prostate cancer	2.19e-05	0.000158	CcSEcCtD
Phenytoin—Shock—Prednisone—prostate cancer	2.18e-05	0.000157	CcSEcCtD
Phenytoin—Nervous system disorder—Prednisone—prostate cancer	2.17e-05	0.000157	CcSEcCtD
Phenytoin—Tachycardia—Prednisone—prostate cancer	2.16e-05	0.000156	CcSEcCtD
Phenytoin—Decreased appetite—Capecitabine—prostate cancer	2.16e-05	0.000156	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Capecitabine—prostate cancer	2.15e-05	0.000155	CcSEcCtD
Phenytoin—Fatigue—Capecitabine—prostate cancer	2.14e-05	0.000155	CcSEcCtD
Phenytoin—Hyperhidrosis—Prednisone—prostate cancer	2.14e-05	0.000155	CcSEcCtD
Phenytoin—Erythema multiforme—Doxorubicin—prostate cancer	2.13e-05	0.000154	CcSEcCtD
Phenytoin—Constipation—Capecitabine—prostate cancer	2.13e-05	0.000154	CcSEcCtD
Phenytoin—Feeling abnormal—Docetaxel—prostate cancer	2.12e-05	0.000153	CcSEcCtD
Phenytoin—Diarrhoea—Etoposide—prostate cancer	2.11e-05	0.000153	CcSEcCtD
Phenytoin—Anorexia—Prednisone—prostate cancer	2.11e-05	0.000152	CcSEcCtD
Phenytoin—Tinnitus—Doxorubicin—prostate cancer	2.1e-05	0.000152	CcSEcCtD
Phenytoin—Flatulence—Epirubicin—prostate cancer	2.09e-05	0.000151	CcSEcCtD
Phenytoin—Tension—Epirubicin—prostate cancer	2.08e-05	0.00015	CcSEcCtD
Phenytoin—Dysgeusia—Epirubicin—prostate cancer	2.08e-05	0.00015	CcSEcCtD
Phenytoin—Nervousness—Epirubicin—prostate cancer	2.06e-05	0.000149	CcSEcCtD
Phenytoin—Back pain—Epirubicin—prostate cancer	2.05e-05	0.000148	CcSEcCtD
Phenytoin—Feeling abnormal—Capecitabine—prostate cancer	2.05e-05	0.000148	CcSEcCtD
Phenytoin—Dizziness—Etoposide—prostate cancer	2.04e-05	0.000148	CcSEcCtD
Phenytoin—Muscle spasms—Epirubicin—prostate cancer	2.04e-05	0.000147	CcSEcCtD
Phenytoin—Immune system disorder—Doxorubicin—prostate cancer	2.04e-05	0.000147	CcSEcCtD
Phenytoin—Body temperature increased—Docetaxel—prostate cancer	2.03e-05	0.000147	CcSEcCtD
Phenytoin—Chills—Doxorubicin—prostate cancer	2.02e-05	0.000146	CcSEcCtD
Phenytoin—Musculoskeletal discomfort—Prednisone—prostate cancer	2.02e-05	0.000146	CcSEcCtD
Phenytoin—Insomnia—Prednisone—prostate cancer	2e-05	0.000145	CcSEcCtD
Phenytoin—Paraesthesia—Prednisone—prostate cancer	1.99e-05	0.000144	CcSEcCtD
Phenytoin—Urticaria—Capecitabine—prostate cancer	1.98e-05	0.000143	CcSEcCtD
Phenytoin—Ill-defined disorder—Epirubicin—prostate cancer	1.97e-05	0.000142	CcSEcCtD
Phenytoin—Body temperature increased—Capecitabine—prostate cancer	1.97e-05	0.000142	CcSEcCtD
Phenytoin—Vomiting—Etoposide—prostate cancer	1.97e-05	0.000142	CcSEcCtD
Phenytoin—Anaemia—Epirubicin—prostate cancer	1.96e-05	0.000142	CcSEcCtD
Phenytoin—Agitation—Epirubicin—prostate cancer	1.95e-05	0.000141	CcSEcCtD
Phenytoin—Dyspepsia—Prednisone—prostate cancer	1.95e-05	0.000141	CcSEcCtD
Phenytoin—Rash—Etoposide—prostate cancer	1.95e-05	0.000141	CcSEcCtD
Phenytoin—Dermatitis—Etoposide—prostate cancer	1.95e-05	0.000141	CcSEcCtD
Phenytoin—Headache—Etoposide—prostate cancer	1.94e-05	0.00014	CcSEcCtD
Phenytoin—Flatulence—Doxorubicin—prostate cancer	1.94e-05	0.00014	CcSEcCtD
Phenytoin—Tension—Doxorubicin—prostate cancer	1.93e-05	0.000139	CcSEcCtD
Phenytoin—Decreased appetite—Prednisone—prostate cancer	1.93e-05	0.000139	CcSEcCtD
Phenytoin—Dysgeusia—Doxorubicin—prostate cancer	1.92e-05	0.000139	CcSEcCtD
Phenytoin—Malaise—Epirubicin—prostate cancer	1.91e-05	0.000138	CcSEcCtD
Phenytoin—Fatigue—Prednisone—prostate cancer	1.91e-05	0.000138	CcSEcCtD
Phenytoin—Nervousness—Doxorubicin—prostate cancer	1.91e-05	0.000138	CcSEcCtD
Phenytoin—Vertigo—Epirubicin—prostate cancer	1.91e-05	0.000138	CcSEcCtD
Phenytoin—Syncope—Epirubicin—prostate cancer	1.9e-05	0.000137	CcSEcCtD
Phenytoin—Leukopenia—Epirubicin—prostate cancer	1.9e-05	0.000137	CcSEcCtD
Phenytoin—Back pain—Doxorubicin—prostate cancer	1.9e-05	0.000137	CcSEcCtD
Phenytoin—Constipation—Prednisone—prostate cancer	1.89e-05	0.000137	CcSEcCtD
Phenytoin—Hypersensitivity—Docetaxel—prostate cancer	1.89e-05	0.000137	CcSEcCtD
Phenytoin—Muscle spasms—Doxorubicin—prostate cancer	1.89e-05	0.000136	CcSEcCtD
Phenytoin—Palpitations—Epirubicin—prostate cancer	1.88e-05	0.000135	CcSEcCtD
Phenytoin—Loss of consciousness—Epirubicin—prostate cancer	1.87e-05	0.000135	CcSEcCtD
Phenytoin—Cough—Epirubicin—prostate cancer	1.85e-05	0.000134	CcSEcCtD
Phenytoin—Asthenia—Docetaxel—prostate cancer	1.84e-05	0.000133	CcSEcCtD
Phenytoin—Convulsion—Epirubicin—prostate cancer	1.84e-05	0.000133	CcSEcCtD
Phenytoin—Nausea—Etoposide—prostate cancer	1.84e-05	0.000133	CcSEcCtD
Phenytoin—Hypertension—Epirubicin—prostate cancer	1.83e-05	0.000132	CcSEcCtD
Phenytoin—Hypersensitivity—Capecitabine—prostate cancer	1.83e-05	0.000132	CcSEcCtD
Phenytoin—Feeling abnormal—Prednisone—prostate cancer	1.83e-05	0.000132	CcSEcCtD
Phenytoin—Ill-defined disorder—Doxorubicin—prostate cancer	1.82e-05	0.000132	CcSEcCtD
Phenytoin—Pruritus—Docetaxel—prostate cancer	1.82e-05	0.000131	CcSEcCtD
Phenytoin—Anaemia—Doxorubicin—prostate cancer	1.82e-05	0.000131	CcSEcCtD
Phenytoin—Chest pain—Epirubicin—prostate cancer	1.81e-05	0.00013	CcSEcCtD
Phenytoin—Arthralgia—Epirubicin—prostate cancer	1.81e-05	0.00013	CcSEcCtD
Phenytoin—Myalgia—Epirubicin—prostate cancer	1.81e-05	0.00013	CcSEcCtD
Phenytoin—Agitation—Doxorubicin—prostate cancer	1.81e-05	0.00013	CcSEcCtD
Phenytoin—Discomfort—Epirubicin—prostate cancer	1.79e-05	0.000129	CcSEcCtD
Phenytoin—Asthenia—Capecitabine—prostate cancer	1.78e-05	0.000129	CcSEcCtD
Phenytoin—Malaise—Doxorubicin—prostate cancer	1.77e-05	0.000128	CcSEcCtD
Phenytoin—Dry mouth—Epirubicin—prostate cancer	1.77e-05	0.000128	CcSEcCtD
Phenytoin—Vertigo—Doxorubicin—prostate cancer	1.76e-05	0.000127	CcSEcCtD
Phenytoin—Syncope—Doxorubicin—prostate cancer	1.76e-05	0.000127	CcSEcCtD
Phenytoin—Urticaria—Prednisone—prostate cancer	1.76e-05	0.000127	CcSEcCtD
Phenytoin—Pruritus—Capecitabine—prostate cancer	1.76e-05	0.000127	CcSEcCtD
Phenytoin—Leukopenia—Doxorubicin—prostate cancer	1.76e-05	0.000127	CcSEcCtD
Phenytoin—Diarrhoea—Docetaxel—prostate cancer	1.76e-05	0.000127	CcSEcCtD
Phenytoin—Body temperature increased—Prednisone—prostate cancer	1.75e-05	0.000126	CcSEcCtD
Phenytoin—Confusional state—Epirubicin—prostate cancer	1.75e-05	0.000126	CcSEcCtD
Phenytoin—Palpitations—Doxorubicin—prostate cancer	1.74e-05	0.000125	CcSEcCtD
Phenytoin—Anaphylactic shock—Epirubicin—prostate cancer	1.73e-05	0.000125	CcSEcCtD
Phenytoin—Loss of consciousness—Doxorubicin—prostate cancer	1.73e-05	0.000125	CcSEcCtD
Phenytoin—Infection—Epirubicin—prostate cancer	1.72e-05	0.000124	CcSEcCtD
Phenytoin—Cough—Doxorubicin—prostate cancer	1.71e-05	0.000124	CcSEcCtD
Phenytoin—Shock—Epirubicin—prostate cancer	1.7e-05	0.000123	CcSEcCtD
Phenytoin—Convulsion—Doxorubicin—prostate cancer	1.7e-05	0.000123	CcSEcCtD
Phenytoin—Diarrhoea—Capecitabine—prostate cancer	1.7e-05	0.000123	CcSEcCtD
Phenytoin—Nervous system disorder—Epirubicin—prostate cancer	1.7e-05	0.000123	CcSEcCtD
Phenytoin—Dizziness—Docetaxel—prostate cancer	1.7e-05	0.000123	CcSEcCtD
Phenytoin—Thrombocytopenia—Epirubicin—prostate cancer	1.7e-05	0.000122	CcSEcCtD
Phenytoin—Hypertension—Doxorubicin—prostate cancer	1.7e-05	0.000122	CcSEcCtD
Phenytoin—Tachycardia—Epirubicin—prostate cancer	1.69e-05	0.000122	CcSEcCtD
Phenytoin—Hyperhidrosis—Epirubicin—prostate cancer	1.67e-05	0.000121	CcSEcCtD
Phenytoin—Arthralgia—Doxorubicin—prostate cancer	1.67e-05	0.000121	CcSEcCtD
Phenytoin—Myalgia—Doxorubicin—prostate cancer	1.67e-05	0.000121	CcSEcCtD
Phenytoin—Chest pain—Doxorubicin—prostate cancer	1.67e-05	0.000121	CcSEcCtD
Phenytoin—Discomfort—Doxorubicin—prostate cancer	1.65e-05	0.000119	CcSEcCtD
Phenytoin—Anorexia—Epirubicin—prostate cancer	1.65e-05	0.000119	CcSEcCtD
Phenytoin—Dizziness—Capecitabine—prostate cancer	1.64e-05	0.000119	CcSEcCtD
Phenytoin—Dry mouth—Doxorubicin—prostate cancer	1.64e-05	0.000118	CcSEcCtD
Phenytoin—Vomiting—Docetaxel—prostate cancer	1.63e-05	0.000118	CcSEcCtD
Phenytoin—Hypersensitivity—Prednisone—prostate cancer	1.63e-05	0.000118	CcSEcCtD
Phenytoin—Rash—Docetaxel—prostate cancer	1.62e-05	0.000117	CcSEcCtD
Phenytoin—Hypotension—Epirubicin—prostate cancer	1.62e-05	0.000117	CcSEcCtD
Phenytoin—Dermatitis—Docetaxel—prostate cancer	1.62e-05	0.000117	CcSEcCtD
Phenytoin—Confusional state—Doxorubicin—prostate cancer	1.62e-05	0.000117	CcSEcCtD
Phenytoin—Headache—Docetaxel—prostate cancer	1.61e-05	0.000116	CcSEcCtD
Phenytoin—Anaphylactic shock—Doxorubicin—prostate cancer	1.6e-05	0.000116	CcSEcCtD
Phenytoin—Infection—Doxorubicin—prostate cancer	1.59e-05	0.000115	CcSEcCtD
Phenytoin—Asthenia—Prednisone—prostate cancer	1.59e-05	0.000115	CcSEcCtD
Phenytoin—Vomiting—Capecitabine—prostate cancer	1.58e-05	0.000114	CcSEcCtD
Phenytoin—Musculoskeletal discomfort—Epirubicin—prostate cancer	1.58e-05	0.000114	CcSEcCtD
Phenytoin—Shock—Doxorubicin—prostate cancer	1.58e-05	0.000114	CcSEcCtD
Phenytoin—Nervous system disorder—Doxorubicin—prostate cancer	1.57e-05	0.000114	CcSEcCtD
Phenytoin—Thrombocytopenia—Doxorubicin—prostate cancer	1.57e-05	0.000113	CcSEcCtD
Phenytoin—Rash—Capecitabine—prostate cancer	1.57e-05	0.000113	CcSEcCtD
Phenytoin—Pruritus—Prednisone—prostate cancer	1.57e-05	0.000113	CcSEcCtD
Phenytoin—Insomnia—Epirubicin—prostate cancer	1.57e-05	0.000113	CcSEcCtD
Phenytoin—Dermatitis—Capecitabine—prostate cancer	1.57e-05	0.000113	CcSEcCtD
Phenytoin—Tachycardia—Doxorubicin—prostate cancer	1.56e-05	0.000113	CcSEcCtD
Phenytoin—Headache—Capecitabine—prostate cancer	1.56e-05	0.000112	CcSEcCtD
Phenytoin—Paraesthesia—Epirubicin—prostate cancer	1.56e-05	0.000112	CcSEcCtD
Phenytoin—Hyperhidrosis—Doxorubicin—prostate cancer	1.55e-05	0.000112	CcSEcCtD
Phenytoin—Dyspnoea—Epirubicin—prostate cancer	1.54e-05	0.000112	CcSEcCtD
Phenytoin—Somnolence—Epirubicin—prostate cancer	1.54e-05	0.000111	CcSEcCtD
Phenytoin—Anorexia—Doxorubicin—prostate cancer	1.53e-05	0.00011	CcSEcCtD
Phenytoin—Nausea—Docetaxel—prostate cancer	1.53e-05	0.00011	CcSEcCtD
Phenytoin—Dyspepsia—Epirubicin—prostate cancer	1.53e-05	0.00011	CcSEcCtD
Phenytoin—Diarrhoea—Prednisone—prostate cancer	1.52e-05	0.000109	CcSEcCtD
Phenytoin—Decreased appetite—Epirubicin—prostate cancer	1.51e-05	0.000109	CcSEcCtD
Phenytoin—Hypotension—Doxorubicin—prostate cancer	1.5e-05	0.000108	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Epirubicin—prostate cancer	1.5e-05	0.000108	CcSEcCtD
Phenytoin—Fatigue—Epirubicin—prostate cancer	1.49e-05	0.000108	CcSEcCtD
Phenytoin—Constipation—Epirubicin—prostate cancer	1.48e-05	0.000107	CcSEcCtD
Phenytoin—Nausea—Capecitabine—prostate cancer	1.48e-05	0.000107	CcSEcCtD
Phenytoin—Dizziness—Prednisone—prostate cancer	1.46e-05	0.000106	CcSEcCtD
Phenytoin—Musculoskeletal discomfort—Doxorubicin—prostate cancer	1.46e-05	0.000105	CcSEcCtD
Phenytoin—Insomnia—Doxorubicin—prostate cancer	1.45e-05	0.000105	CcSEcCtD
Phenytoin—Paraesthesia—Doxorubicin—prostate cancer	1.44e-05	0.000104	CcSEcCtD
Phenytoin—Dyspnoea—Doxorubicin—prostate cancer	1.43e-05	0.000103	CcSEcCtD
Phenytoin—Feeling abnormal—Epirubicin—prostate cancer	1.43e-05	0.000103	CcSEcCtD
Phenytoin—Somnolence—Doxorubicin—prostate cancer	1.43e-05	0.000103	CcSEcCtD
Phenytoin—Dyspepsia—Doxorubicin—prostate cancer	1.41e-05	0.000102	CcSEcCtD
Phenytoin—Vomiting—Prednisone—prostate cancer	1.41e-05	0.000102	CcSEcCtD
Phenytoin—Rash—Prednisone—prostate cancer	1.4e-05	0.000101	CcSEcCtD
Phenytoin—Dermatitis—Prednisone—prostate cancer	1.4e-05	0.000101	CcSEcCtD
Phenytoin—Decreased appetite—Doxorubicin—prostate cancer	1.39e-05	0.000101	CcSEcCtD
Phenytoin—Headache—Prednisone—prostate cancer	1.39e-05	0.0001	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Doxorubicin—prostate cancer	1.38e-05	9.99e-05	CcSEcCtD
Phenytoin—Fatigue—Doxorubicin—prostate cancer	1.38e-05	9.98e-05	CcSEcCtD
Phenytoin—Urticaria—Epirubicin—prostate cancer	1.38e-05	9.94e-05	CcSEcCtD
Phenytoin—Constipation—Doxorubicin—prostate cancer	1.37e-05	9.9e-05	CcSEcCtD
Phenytoin—Body temperature increased—Epirubicin—prostate cancer	1.37e-05	9.89e-05	CcSEcCtD
Phenytoin—Feeling abnormal—Doxorubicin—prostate cancer	1.32e-05	9.54e-05	CcSEcCtD
Phenytoin—Nausea—Prednisone—prostate cancer	1.32e-05	9.5e-05	CcSEcCtD
Phenytoin—Hypersensitivity—Epirubicin—prostate cancer	1.28e-05	9.22e-05	CcSEcCtD
Phenytoin—Urticaria—Doxorubicin—prostate cancer	1.27e-05	9.2e-05	CcSEcCtD
Phenytoin—Body temperature increased—Doxorubicin—prostate cancer	1.27e-05	9.15e-05	CcSEcCtD
Phenytoin—Asthenia—Epirubicin—prostate cancer	1.24e-05	8.98e-05	CcSEcCtD
Phenytoin—Pruritus—Epirubicin—prostate cancer	1.23e-05	8.85e-05	CcSEcCtD
Phenytoin—Diarrhoea—Epirubicin—prostate cancer	1.19e-05	8.56e-05	CcSEcCtD
Phenytoin—Hypersensitivity—Doxorubicin—prostate cancer	1.18e-05	8.53e-05	CcSEcCtD
Phenytoin—Asthenia—Doxorubicin—prostate cancer	1.15e-05	8.3e-05	CcSEcCtD
Phenytoin—Dizziness—Epirubicin—prostate cancer	1.15e-05	8.27e-05	CcSEcCtD
Phenytoin—Pruritus—Doxorubicin—prostate cancer	1.13e-05	8.19e-05	CcSEcCtD
Phenytoin—Vomiting—Epirubicin—prostate cancer	1.1e-05	7.95e-05	CcSEcCtD
Phenytoin—Diarrhoea—Doxorubicin—prostate cancer	1.1e-05	7.92e-05	CcSEcCtD
Phenytoin—Rash—Epirubicin—prostate cancer	1.09e-05	7.89e-05	CcSEcCtD
Phenytoin—Dermatitis—Epirubicin—prostate cancer	1.09e-05	7.88e-05	CcSEcCtD
Phenytoin—Headache—Epirubicin—prostate cancer	1.09e-05	7.84e-05	CcSEcCtD
Phenytoin—Dizziness—Doxorubicin—prostate cancer	1.06e-05	7.65e-05	CcSEcCtD
Phenytoin—Nausea—Epirubicin—prostate cancer	1.03e-05	7.43e-05	CcSEcCtD
Phenytoin—Vomiting—Doxorubicin—prostate cancer	1.02e-05	7.36e-05	CcSEcCtD
Phenytoin—Rash—Doxorubicin—prostate cancer	1.01e-05	7.3e-05	CcSEcCtD
Phenytoin—Dermatitis—Doxorubicin—prostate cancer	1.01e-05	7.29e-05	CcSEcCtD
Phenytoin—Headache—Doxorubicin—prostate cancer	1e-05	7.25e-05	CcSEcCtD
Phenytoin—Nausea—Doxorubicin—prostate cancer	9.52e-06	6.88e-05	CcSEcCtD
Phenytoin—ABCB1—Metabolism—TH—prostate cancer	1.53e-06	1.61e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—CYP1A1—prostate cancer	1.53e-06	1.6e-05	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—SRC—prostate cancer	1.53e-06	1.6e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—CYP1B1—prostate cancer	1.53e-06	1.6e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—ERCC2—prostate cancer	1.52e-06	1.59e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—CYP3A4—prostate cancer	1.52e-06	1.59e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.51e-06	1.58e-05	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—CREBBP—prostate cancer	1.51e-06	1.58e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—SLC5A5—prostate cancer	1.51e-06	1.58e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—GSTA1—prostate cancer	1.51e-06	1.58e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.5e-06	1.57e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—CYP1A1—prostate cancer	1.5e-06	1.57e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—COMT—prostate cancer	1.5e-06	1.57e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—CYP1B1—prostate cancer	1.49e-06	1.56e-05	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—VEGFA—prostate cancer	1.49e-06	1.56e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—GSTP1—prostate cancer	1.49e-06	1.56e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—COMT—prostate cancer	1.49e-06	1.56e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—NAT2—prostate cancer	1.49e-06	1.56e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—HSD3B2—prostate cancer	1.49e-06	1.56e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—GSTO1—prostate cancer	1.49e-06	1.56e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—ERCC2—prostate cancer	1.49e-06	1.56e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—GSTP1—prostate cancer	1.48e-06	1.55e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—GGT1—prostate cancer	1.48e-06	1.55e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—CYP2E1—prostate cancer	1.47e-06	1.54e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—ITPR1—prostate cancer	1.47e-06	1.53e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—NCOA1—prostate cancer	1.46e-06	1.53e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—ITPR1—prostate cancer	1.46e-06	1.53e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—NQO1—prostate cancer	1.45e-06	1.52e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—GGT1—prostate cancer	1.45e-06	1.51e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.44e-06	1.51e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—CYP19A1—prostate cancer	1.44e-06	1.5e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.43e-06	1.5e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—TH—prostate cancer	1.43e-06	1.5e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—MTHFR—prostate cancer	1.43e-06	1.5e-05	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—PIK3CD—prostate cancer	1.43e-06	1.49e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—PLCB2—prostate cancer	1.43e-06	1.49e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—LRP2—prostate cancer	1.43e-06	1.49e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—CYP2C18—prostate cancer	1.43e-06	1.49e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.42e-06	1.49e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—NCOA1—prostate cancer	1.42e-06	1.49e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—CYP3A4—prostate cancer	1.42e-06	1.48e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.41e-06	1.48e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—CYP19A1—prostate cancer	1.4e-06	1.47e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—PPARA—prostate cancer	1.4e-06	1.47e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—P4HB—prostate cancer	1.4e-06	1.46e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—MTHFR—prostate cancer	1.4e-06	1.46e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—CYP1B1—prostate cancer	1.39e-06	1.46e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—RXRA—prostate cancer	1.39e-06	1.45e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—TYMS—prostate cancer	1.39e-06	1.45e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—TYMS—prostate cancer	1.38e-06	1.44e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—PPARA—prostate cancer	1.37e-06	1.43e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—GSTM1—prostate cancer	1.37e-06	1.43e-05	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—TGFB1—prostate cancer	1.37e-06	1.43e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—GSTM1—prostate cancer	1.36e-06	1.43e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—SLC22A1—prostate cancer	1.36e-06	1.42e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—RXRA—prostate cancer	1.35e-06	1.42e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—GGT1—prostate cancer	1.35e-06	1.41e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.35e-06	1.41e-05	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—NOS3—prostate cancer	1.35e-06	1.41e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—LPL—prostate cancer	1.34e-06	1.41e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—LPL—prostate cancer	1.34e-06	1.4e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—COMT—prostate cancer	1.34e-06	1.4e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—GSTP1—prostate cancer	1.33e-06	1.39e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—NCOA1—prostate cancer	1.33e-06	1.39e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—SULT2A1—prostate cancer	1.33e-06	1.39e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—CAV1—prostate cancer	1.32e-06	1.38e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—CYP19A1—prostate cancer	1.31e-06	1.37e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—ITPR1—prostate cancer	1.31e-06	1.37e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—MED12—prostate cancer	1.31e-06	1.37e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—COMT—prostate cancer	1.3e-06	1.37e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—GSTP1—prostate cancer	1.3e-06	1.36e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—CYP1A1—prostate cancer	1.3e-06	1.36e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—GNG5—prostate cancer	1.3e-06	1.35e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—CYP1A1—prostate cancer	1.29e-06	1.35e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—CAV1—prostate cancer	1.29e-06	1.35e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—ERCC2—prostate cancer	1.29e-06	1.35e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.29e-06	1.35e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—ERCC2—prostate cancer	1.28e-06	1.34e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—ITPR1—prostate cancer	1.28e-06	1.34e-05	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—KRAS—prostate cancer	1.27e-06	1.33e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—RXRA—prostate cancer	1.27e-06	1.32e-05	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism—AKT1—prostate cancer	1.26e-06	1.32e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—NCOA3—prostate cancer	1.25e-06	1.31e-05	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—PIK3CB—prostate cancer	1.24e-06	1.3e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—TYMS—prostate cancer	1.24e-06	1.29e-05	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—PTGS2—prostate cancer	1.23e-06	1.29e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.23e-06	1.29e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—GSTM1—prostate cancer	1.22e-06	1.28e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—COMT—prostate cancer	1.22e-06	1.28e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—GSTP1—prostate cancer	1.21e-06	1.27e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—MTHFR—prostate cancer	1.21e-06	1.27e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—TYMS—prostate cancer	1.21e-06	1.26e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—MTHFR—prostate cancer	1.2e-06	1.26e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—PIK3CG—prostate cancer	1.2e-06	1.26e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—LPL—prostate cancer	1.2e-06	1.26e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—ITPR1—prostate cancer	1.19e-06	1.25e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—GSTM1—prostate cancer	1.19e-06	1.25e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—HPGDS—prostate cancer	1.19e-06	1.25e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—PPARA—prostate cancer	1.19e-06	1.24e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—CYP2C19—prostate cancer	1.18e-06	1.24e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—PPARA—prostate cancer	1.18e-06	1.24e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—PIK3CG—prostate cancer	1.17e-06	1.23e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.17e-06	1.23e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—LPL—prostate cancer	1.17e-06	1.23e-05	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—PIK3CA—prostate cancer	1.17e-06	1.22e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—CYP1A1—prostate cancer	1.16e-06	1.21e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—ACHE—prostate cancer	1.15e-06	1.21e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—GSTT1—prostate cancer	1.15e-06	1.21e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—ERCC2—prostate cancer	1.15e-06	1.2e-05	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—PIK3CA—prostate cancer	1.14e-06	1.19e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—CYP2A6—prostate cancer	1.14e-06	1.19e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—INS—prostate cancer	1.14e-06	1.19e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—CYP1A1—prostate cancer	1.13e-06	1.18e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—TYMS—prostate cancer	1.13e-06	1.18e-05	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—TP53—prostate cancer	1.13e-06	1.18e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—ERCC2—prostate cancer	1.12e-06	1.17e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—CAV1—prostate cancer	1.12e-06	1.17e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—GSTM1—prostate cancer	1.11e-06	1.17e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—CREBBP—prostate cancer	1.11e-06	1.17e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—INS—prostate cancer	1.11e-06	1.16e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—CAV1—prostate cancer	1.11e-06	1.16e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—AKR1C3—prostate cancer	1.11e-06	1.16e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—PRKACB—prostate cancer	1.1e-06	1.16e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—LPL—prostate cancer	1.09e-06	1.14e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—CYP17A1—prostate cancer	1.09e-06	1.14e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—CREBBP—prostate cancer	1.09e-06	1.14e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—MTHFR—prostate cancer	1.08e-06	1.13e-05	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—PTEN—prostate cancer	1.08e-06	1.13e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.07e-06	1.12e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.06e-06	1.11e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—PPARA—prostate cancer	1.06e-06	1.11e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—CYP1A1—prostate cancer	1.06e-06	1.11e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—PIK3CD—prostate cancer	1.06e-06	1.11e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—MTHFR—prostate cancer	1.05e-06	1.1e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—ERCC2—prostate cancer	1.05e-06	1.1e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—NCOA2—prostate cancer	1.04e-06	1.09e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—PPARA—prostate cancer	1.03e-06	1.08e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—PIK3CD—prostate cancer	1.03e-06	1.08e-05	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—EP300—prostate cancer	1.03e-06	1.07e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—PIK3CG—prostate cancer	1.02e-06	1.06e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—PIK3CG—prostate cancer	1.01e-06	1.06e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—NOS3—prostate cancer	9.97e-07	1.04e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—CAV1—prostate cancer	9.97e-07	1.04e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—SLC5A5—prostate cancer	9.93e-07	1.04e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—MTHFR—prostate cancer	9.85e-07	1.03e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—NOS3—prostate cancer	9.75e-07	1.02e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—CAV1—prostate cancer	9.73e-07	1.02e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—CYP2E1—prostate cancer	9.7e-07	1.02e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—PPARA—prostate cancer	9.67e-07	1.01e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—INS—prostate cancer	9.63e-07	1.01e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—NQO1—prostate cancer	9.59e-07	1e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—INS—prostate cancer	9.57e-07	1e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	9.52e-07	9.96e-06	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—AKT1—prostate cancer	9.52e-07	9.96e-06	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—TH—prostate cancer	9.45e-07	9.89e-06	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—CREBBP—prostate cancer	9.43e-07	9.87e-06	CbGpPWpGaD
Phenytoin—ALB—Metabolism—CREBBP—prostate cancer	9.38e-07	9.81e-06	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—AKT1—prostate cancer	9.32e-07	9.76e-06	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—PIK3CB—prostate cancer	9.21e-07	9.63e-06	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—CYP1B1—prostate cancer	9.2e-07	9.62e-06	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—PTGS2—prostate cancer	9.12e-07	9.54e-06	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—CAV1—prostate cancer	9.09e-07	9.51e-06	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—PIK3CG—prostate cancer	9.08e-07	9.5e-06	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—PIK3CB—prostate cancer	9e-07	9.41e-06	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—PIK3CD—prostate cancer	8.94e-07	9.36e-06	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—PTGS2—prostate cancer	8.92e-07	9.33e-06	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—GGT1—prostate cancer	8.91e-07	9.32e-06	CbGpPWpGaD
Phenytoin—ALB—Metabolism—PIK3CD—prostate cancer	8.89e-07	9.3e-06	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—PIK3CG—prostate cancer	8.86e-07	9.27e-06	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—NCOA1—prostate cancer	8.77e-07	9.18e-06	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	8.68e-07	9.08e-06	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—CYP19A1—prostate cancer	8.65e-07	9.05e-06	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—INS—prostate cancer	8.59e-07	8.99e-06	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—NOS3—prostate cancer	8.44e-07	8.83e-06	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—CREBBP—prostate cancer	8.42e-07	8.81e-06	CbGpPWpGaD
Phenytoin—ALB—Metabolism—NOS3—prostate cancer	8.4e-07	8.78e-06	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—INS—prostate cancer	8.39e-07	8.78e-06	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—RXRA—prostate cancer	8.35e-07	8.73e-06	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—PIK3CG—prostate cancer	8.28e-07	8.66e-06	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—CREBBP—prostate cancer	8.22e-07	8.6e-06	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—COMT—prostate cancer	8.04e-07	8.41e-06	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—GSTP1—prostate cancer	8e-07	8.37e-06	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—PIK3CD—prostate cancer	7.98e-07	8.35e-06	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—PTEN—prostate cancer	7.95e-07	8.32e-06	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—ITPR1—prostate cancer	7.87e-07	8.24e-06	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—INS—prostate cancer	7.84e-07	8.2e-06	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—PIK3CB—prostate cancer	7.79e-07	8.15e-06	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—PIK3CD—prostate cancer	7.79e-07	8.15e-06	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—PTEN—prostate cancer	7.78e-07	8.14e-06	CbGpPWpGaD
Phenytoin—ALB—Metabolism—PIK3CB—prostate cancer	7.75e-07	8.11e-06	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—PTGS2—prostate cancer	7.72e-07	8.08e-06	CbGpPWpGaD
Phenytoin—ALB—Metabolism—PTGS2—prostate cancer	7.68e-07	8.03e-06	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—CREBBP—prostate cancer	7.67e-07	8.03e-06	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—PIK3CA—prostate cancer	7.59e-07	7.94e-06	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—EP300—prostate cancer	7.59e-07	7.94e-06	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—NOS3—prostate cancer	7.54e-07	7.89e-06	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—TYMS—prostate cancer	7.44e-07	7.78e-06	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—EP300—prostate cancer	7.41e-07	7.76e-06	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—NOS3—prostate cancer	7.36e-07	7.7e-06	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—GSTM1—prostate cancer	7.35e-07	7.69e-06	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—PIK3CD—prostate cancer	7.28e-07	7.61e-06	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—LPL—prostate cancer	7.22e-07	7.55e-06	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—CYP1A1—prostate cancer	6.97e-07	7.29e-06	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—PIK3CB—prostate cancer	6.96e-07	7.28e-06	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—ERCC2—prostate cancer	6.91e-07	7.23e-06	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—PTGS2—prostate cancer	6.89e-07	7.21e-06	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—NOS3—prostate cancer	6.87e-07	7.19e-06	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—PIK3CB—prostate cancer	6.79e-07	7.1e-06	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—PTEN—prostate cancer	6.73e-07	7.05e-06	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—PTGS2—prostate cancer	6.73e-07	7.04e-06	CbGpPWpGaD
Phenytoin—ALB—Metabolism—PTEN—prostate cancer	6.7e-07	7.01e-06	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—MTHFR—prostate cancer	6.5e-07	6.8e-06	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—EP300—prostate cancer	6.42e-07	6.72e-06	CbGpPWpGaD
Phenytoin—ALB—Metabolism—EP300—prostate cancer	6.39e-07	6.68e-06	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—PPARA—prostate cancer	6.37e-07	6.67e-06	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—PIK3CB—prostate cancer	6.34e-07	6.64e-06	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—PTGS2—prostate cancer	6.28e-07	6.58e-06	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—AKT1—prostate cancer	6.2e-07	6.49e-06	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—PTEN—prostate cancer	6.01e-07	6.29e-06	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—CAV1—prostate cancer	5.99e-07	6.27e-06	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—PTEN—prostate cancer	5.87e-07	6.14e-06	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—EP300—prostate cancer	5.73e-07	6e-06	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—PIK3CA—prostate cancer	5.61e-07	5.87e-06	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—EP300—prostate cancer	5.6e-07	5.85e-06	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—PIK3CA—prostate cancer	5.49e-07	5.74e-06	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—PTEN—prostate cancer	5.48e-07	5.73e-06	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—PIK3CG—prostate cancer	5.46e-07	5.71e-06	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—EP300—prostate cancer	5.23e-07	5.47e-06	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—INS—prostate cancer	5.17e-07	5.41e-06	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—CREBBP—prostate cancer	5.06e-07	5.3e-06	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—PIK3CD—prostate cancer	4.8e-07	5.02e-06	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—PIK3CA—prostate cancer	4.75e-07	4.97e-06	CbGpPWpGaD
Phenytoin—ALB—Metabolism—PIK3CA—prostate cancer	4.72e-07	4.94e-06	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—AKT1—prostate cancer	4.58e-07	4.8e-06	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—NOS3—prostate cancer	4.53e-07	4.74e-06	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—AKT1—prostate cancer	4.48e-07	4.69e-06	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—PIK3CA—prostate cancer	4.24e-07	4.44e-06	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—PIK3CB—prostate cancer	4.18e-07	4.38e-06	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—PTGS2—prostate cancer	4.14e-07	4.34e-06	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—PIK3CA—prostate cancer	4.14e-07	4.33e-06	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—AKT1—prostate cancer	3.88e-07	4.06e-06	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—PIK3CA—prostate cancer	3.87e-07	4.05e-06	CbGpPWpGaD
Phenytoin—ALB—Metabolism—AKT1—prostate cancer	3.86e-07	4.04e-06	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—PTEN—prostate cancer	3.61e-07	3.78e-06	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—AKT1—prostate cancer	3.46e-07	3.62e-06	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—EP300—prostate cancer	3.45e-07	3.61e-06	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—AKT1—prostate cancer	3.38e-07	3.54e-06	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—AKT1—prostate cancer	3.16e-07	3.3e-06	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—PIK3CA—prostate cancer	2.55e-07	2.67e-06	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—AKT1—prostate cancer	2.08e-07	2.18e-06	CbGpPWpGaD
